(CNN) – The Centers for Control and Prevention of Infants of EE. UU. and the EE Food and Drug Administration. UU. recommends that the pauses pause the use of the Johnson & Johnson covid-19 vacancy tras “six rare cases of a severe type of coagulation reported in EE.UU.”
The six notified cases are located between the more than 6.8 million doses of the Johnson & Johnson vaccine administered in the United States. The six cases occurred between women 18 and 48 years old, and the symptoms occurred from 6 to 13 days after the evacuation, according to a joint statement on March. Anne Schuchat, deputy director of the CDC and dr. Peter Marks, Director of the FDA’s Center for Evaluation and Investigation of Biological Products.
15 million Johnson & Johnson vacancies against covid-19 quedaron arruinadas; this is what happened
“The CDC will convene a meeting of the Assessment Committee on the Practice of Immunization (ACIP) the markets to review more in depth these cases and evaluate their potential importance,” the communication said.
“The FDA is reviewing this analysis and is also investigating these cases. Once this process is complete, we recommend taking a break from using this vaccine for precaution. It is important, in part, to ensure that the community of providers is aware of the potential of these adverse events and can plan the reconciliation and treatment required by the only treatment required with this type of song coagulation ».
Colombia authorizes Johnson & Johnson emergency response against covid-19